Related Experiment Video
Updated: Aug 27, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Inhibition of ultra-rapid delayed rectifier K+ current by verapamil in human atrial myocytes
Zhan Gao1, Chu-Pak Lau, Shui-Wah Chiu
1Department of Medicine, and Institute of Cardiovascular Science and Medicine, Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong, China.
Insights
Verapamil, a calcium channel blocker, inhibits the ultra-rapid delayed rectifier potassium current (I(Kur)) in human atrial cells. This drug does not affect the transient outward potassium current (I(to1)), potentially explaining its atrial effects.
Area of Science:
- Cardiovascular pharmacology
- Electrophysiology
- Ion channel research
Background:
- Verapamil is a common calcium channel antagonist for cardiovascular disorders.
- Its effects on human atrial repolarization currents, specifically I(to1) and I(Kur), are not well understood.
Purpose of the Study:
- To investigate the impact of verapamil on transient outward potassium current (I(to1)) and ultra-rapid delayed rectifier potassium current (I(Kur)) in human atrial myocytes.
- To elucidate the mechanism of verapamil's action on these currents.
Main Methods:
- Whole-cell patch-clamp electrophysiology was used to record ionic currents in isolated human atrial myocytes.
- Verapamil's effects were assessed at varying concentrations (1-50 microM).
Main Results:
- Verapamil did not inhibit I(to1) at concentrations up to 50 microM.
- Verapamil demonstrated a reversible, concentration-dependent inhibition of I(Kur) with an IC(50) of 3.2 microM.
- A concentration of 5 microM verapamil reduced I(Kur) by 61.3 +/- 7.5% and accelerated its inactivation, suggesting open channel block.
Conclusions:
- Verapamil significantly blocks the I(Kur) repolarization current in human atrial cells.
- Verapamil does not inhibit I(to1) in the human atrium.
- The blockade of I(Kur) by verapamil may contribute to its therapeutic effects in atrial arrhythmias.
Abstract:
Verapamil is a widely used Ca(2+) channel antagonist in the treatment of cardiovascular disorders including atrial arrhythmias. However, it is unknown whether the drug would inhibit the repolarization currents transient outward K(+) current (I(to1)) and ultra-rapid delayed rectifier K(+) current (I(Kur)) in human atrium. With whole-cell patch configuration, we evaluated effects of verapamil on I(to1) and I(Kur) in isolated human atrial myocytes. It was found that verapamil did not decrease I(to1) at 1-50 microM. However, verapamil reversibly inhibited I(Kur) in a concentration-dependent manner (IC(50) = 3.2 microM). At test potential of +50 mV, 5 microM verapamil decreased I(Kur) by 61.3 +/- 7.5%. Verapamil significantly accelerated inactivation of I(Kur), suggesting an open channel block mechanism. The results indicate that verapamil significantly blocks the repolarization K(+) current I(Kur), but not I(to1), in human atrial atrium, which may account at least in part for the atrial effect of the drug.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
G-Protein Gated Ion Channels
Sensory organs,...
Dysrhythmias IV: Characteristics of Bradyarrhythmias

